Derleme
BibTex RIS Kaynak Göster

A Neuromuscular Disease: Guillain-Barré Syndrome and Nursing Care

Yıl 2020, , 338 - 346, 31.12.2020
https://doi.org/10.38108/ouhcd.768684

Öz

Guillain Barré Syndrome, which causes deep anxiety and fear in the individual with acutely developing areflexive paralysis, is an autoimmune disease. Although it is a rare neuromuscular disease, case analysis studies have been reported that Guillain Barré Syndrome developed after COVID-19 infection from different countries due to the COVID-19 pandemic affecting the world. Therefore, Guillain-Barré Syndrome has become more important during pandemic period. Since individuals become bedridden with Guillain-Barré Syndrome in a short time, all the needs of them are met by nurses. Within the framework of the roles of counselor, educator, caregiver, manager and comforter, the nurse evaluates the individual with a holistic understanding and provides a professional health care service with patience and devotion. By using professional knowledge, skills and creativity, they perform an effective care in order to maintain cardiopulmonary functions, to meet the nutritional needs of the body, and to protect the skin integrity. Besides; they also take an active part in providing patient safety, determining spiritual and psycho-social support needs due to weary process of the disease and providing necessary guidance and rehabilitation during and after recovery process. With health care services they give, nurses greatly support medical treatment to be performed, make contribution to improvement of prognosis and reduce disease-related mortality and morbidity rates.

Kaynakça

  • Akdemir N, Boyraz S. (2020). Nörolojik sistem hastalıkları ve hemşirelik bakımı. Akdemir N, Birol L, editörler. İç Hastalıkları ve Hemşirelik Bakımı. Akademisyen Kitabevi A.Ş., s. 1151-1152.
  • Alankaya N. (2019). Guillain-Barré sendromu ve bakım yönetimi. Özer S, editör. Olgu Senaryolarıyla İç Hastalıkları Hemşireliği. İstanbul Medikal Sağlık ve Yayıncılık Hiz. Tic. Ltd. Şti., s. 395-400.
  • Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P ve ark. (2020). Guillain-Barré syndrome related to COVID-19 infection. Neurology(R) Neuroimmunology and Neuroinflammation, 7(4), 741.
  • Arnaud S, Budowski C, Ng Wing Tin S, Degos B. (2020). Post SARS-CoV-2 Guillain-Barré syndrome. Clinical Neurophysiology: Official Journal of The International Federationof Clinical Neurophysiology, 131(7), 1652–1654.
  • Askanase AD, Khalili L, Buyon JP. (2020). Thoughts on COVID-19 and autoimmune diseases. Lupus Science & Medicine, 7(1), e000396.
  • Atkinson SB, Carr RL, Maybee P, Haynes D. (2006). The challenges of managing and treating Guillain-Barré syndrome during the acute phase. Dimensions of Critical Care Nursing: DCCN, 25(6), 256–263.
  • Bernsen RA, De Jager AE, Van der Meché FG, Suurmeijer TP. (2006). The effects of Guillain-Barré syndrome on the close relatives of patients during the first year. Journal of The Neurological Sciences, 244(1-2), 69–75.
  • Burns TM. (2008). Guillain-Barré syndrome. Seminars in Neurology, 28(2), 152–167.
  • Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. (2020). COVID-19 may induce guillain-barré syndrome. Revue Neurologique, 176(6), 516–518.
  • Dash S, Pai AR, Kamath U, Rao P. (2015). Pathophysiology and diagnosis of Guillain-Barré syndrome-challenges and needs. The International Journal of Neuroscience, 125(4), 235–240. Defabio AC, Scott TR, Stenberg RT, Simon EL. (2020). Guillain-Barré syndrome in a patient previously diagnosed with COVID-19. The American Journal of Emergency Medicine, S0735-6757(20)30669-0. Advance online publication.
  • Dimachkie MM, Barohn RJ. (2013). Guillain-Barré syndrome and variants. Neurologic Clinics, 31(2), 491–510.
  • Erşil S, Sivrikaya SK. (2016). Kronik hastalıklarda evde bakımda hasta güvenliği. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 3(3), 426-430.
  • Farmakidis C, Inan S, Milstein M, Herskovitz S. (2015). Headache and pain in Guillain-Barré syndrome. Current Pain and Headache Reports, 19(8), 40.
  • Gazioğlu S, Tomak T, Boz C. (2013). Guillain-Barré Sendromunda klinik özellikler ve prognoz. Journal of Neurological Sciences, 30(1), 124-134. Haldeman D, Zulkosky K. (2005). Treatment and nursing care for a patient with guillain-barré syndrome. Dimensions of Critical Care Nursing: DCCN, 24(6), 267–272.
  • Harms M. (2011). Inpatient management of guillain-barré syndrome. The Neurohospitalist, 1(2), 78–84.
  • Hughes RA, Cornblath DR. (2005a). Guillain-Barré syndrome. Lancet (London, England), 366(9497), 1653–1666.
  • Hughes RA, Wijdicks EF, Benson E, Cornblath DR, Hahn AF, Meythaler JM ve ark. (2005b). Supportive care for patients with guillain-barré syndrome. Archives of Neurology, 62(8), 1194–1198.
  • Hughes RA, Swan AV, Van Doorn PA. (2014). Intravenous immunoglobulin for Guillain-Barré syndrome. The Cochrane Database of Systematic Reviews, 2014(9): CD002063.
  • Jorge LL, De Brito AM, Marchi FH, Hara AC, Battistella LR, Riberto M. (2015). New rehabilitation models for neurologic inpatients in Brazil. Disability and Rehabilitation, 37(3), 268–273.
  • Kasar KS, Karadakovan A. (2017). Guillain-Barré sendromu ve bakım yönetimi. Türkiye Klinikleri Hemşirelik Bilimleri Dergisi, 9(1), 79-84.
  • Leonhard SE, Mandarakas MR, Gondim F, Bateman K, Ferreira M, Cornblath DR . (2019). Diagnosis and management of Guillain-Barré syndrome in ten steps. Nature Reviews. Neurology, 15(11), 671–683.
  • Li YC, Bai WZ, Hashikawa T. (2020). The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. Journal of Medical Virology, 92(6), 552–555.
  • Meena AK, Khadilkar SV, Murthy JM. (2011). Treatment guidelines for Guillain-Barré syndrome. Annals of Indian Academy of Neurology, 14(Suppl 1), 73–81.
  • Mollaoğlu M. (2017). Sinir sistemi hastalıkları ve hemşirelik yönetimi. Ovayolu N, Ovayolu Ö, editörler. Temel İç Hastalıkları Hemşireliği ve Farklı Boyutları İle Kronik Hastalıklar. Çukurova Nobel Tıp Kitabevi, s. 83-84.
  • Newswanger DL, Warren CR. (2004). Guillain-Barré syndrome. American Family Physician, 69(10), 2405–2410.
  • Peric S, Milosevic V, Berisavac I, Stojiljkovic O, Beslac-Bumbasirevic L, Marjanovic I ve ark. (2014). Clinical and epidemiological features of Guillain-Barré syndrome in the Western Balkans. Journal of The Peripheral Nervous System: JPNS, 19(4), 317–321.
  • Prada V, Massa F, Salerno A, Fregosi D, Beronio A, Serrati C et al. (2020). Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study. Neurological Sciences, 41(2), 321-327.
  • Rajagopalan S, Baghshomali S, Navarro JC, Kalanuria AA. (2018). Intensive care management of the neuromuscular patient. Textbook of Neuroanesthesia and Neurocritical Care: Volume II - Neurocritical Care, 63–96.
  • Ranjani P, Khanna M, Gupta A, Nagappa M, Taly AB, Haldar P. (2014). Prevalence of fatigue in Guillain-Barré syndrome in neurological rehabilitation setting. Annals of Indian Academy of Neurology, 17(3), 331–335.
  • Sedaghat Z, Karimi N. (2020). Guillain-Barré syndrome associated with COVID-19 infection: A case report. Journal of Clinical Neuroscience: Official Journal of The Neurosurgical Society of Australasia, 76, 233–235. Simatos Arsenault N, Vincent PO, Yu BH, Bastien R, Sweeney A. (2016). Influence of exercise on patients with Guillain-Barré Syndrome: A Systematic Review. Physiotherapy Canada. Physiotherapie Canada, 68(4), 367–376.
  • Sudulagunta SR, Sodalagunta MB, Sepehrar M, Khorram H, Bangalore Raja SK, Kothandapani S ve ark. (2015). Guillain-Barré syndrome: clinical profile and management. German Medical Science: GMS e-journal, 13, Doc16.
  • Sulton LL. (2001). A multidisciplinary care approach to Guillain-Barré syndrome. Dimensions of Critical Care Nursing: DCCN, 20(1), 16–22.
  • Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. (2014). Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews. Neurology, 10(8), 469–482.
  • Vucic S, Kiernan MC, Cornblath DR. (2009). Guillain-barré syndrome: an update. Journal of Clinical Neuroscience: Official Journal of The Neurosurgical Society of Australasia, 16(6), 733–741.
  • Walling AD, Dickson G. (2013). Guillain-Barré syndrome. American Family Physician, 87(3), 191–197.
  • Wilkinson JM, Barcus L. (2018). Nursing Diagnosis Handbook. Kapucu S, Akyar İ, Korkmaz F, çeviri editörleri. Hemşirelik Tanıları El Kitabı. Pelikan Kitabevi, s. 181;192
  • Yao S, Chen H, Zhang Q, Shi Z, Liu J, Lian Z ve ark. (2018). Pain during the acute phase of Guillain-Barré syndrome. Medicine, 97(34), e11595.

Nöromüsküler Bir Hastalık: Guillain Barré Sendromu ve Hemşirelik Bakımı

Yıl 2020, , 338 - 346, 31.12.2020
https://doi.org/10.38108/ouhcd.768684

Öz

Akut gelişen arefleksif felç tablolarının yaşandığı, bireyde derin bir kaygı ve korku yaratan Guillain Barré Sendromu otoimmün kökenli bir hastalıktır. Nadir görülen nöromüsküler bir hastalık olmasına rağmen dünyayı etkisi altına alan COVID-19 pandemisi sebebiyle farklı ülkelerden COVID-19 enfeksiyonu sonrası Guillain Barré Sendromu geliştiğine dair vaka analizi çalışmaları bildirilmektedir. Bu nedenle Guillain Barré Sendromunun pandemi sürecinde önemi artmaktadır. Guillain Barré Sendromu, bireyi kısa sürede yatağa bağımlı hale getirmesi nedeni ile bireyin tüm gereksinimleri hemşire tarafından karşılanır. Danışman, eğitici, bakım verici, yönetici, rahatlatıcı rolleri çerçevesinde hemşire, holistik bir anlayışla bireyi değerlendirerek, sabır ve özveri içerisinde profesyonel bir sağlık bakım hizmeti sunar. Mesleki bilgi, beceri, yaratıcılık yeteneklerini kullanarak kardiyopulmoner fonksiyonların devamlılığı, vücudun besin ihtiyaçlarının karşılanması, cilt bütünlüğünün korunmasında etkili bir bakım gerçekleştirir. Ayrıca hasta güvenliğinin sağlanması, sürecin yıpratıcılığında manevi ve psikososyal destek gereksinimlerinin belirlenmesi ve gerekli rehberliğin yapılması, iyileşme süreci ve sonrasında gerekli rehabilitasyon hizmetlerinin verilmesinde de aktif rol alır. Sunduğu sağlık bakım hizmeti ile hemşire, uygulanan medikal tedaviye büyük destek sağlayarak prognozun iyileşmesine, hastalığa bağlı mortalite ve morbidite oranlarının azalmasına katkıda bulunur.

Kaynakça

  • Akdemir N, Boyraz S. (2020). Nörolojik sistem hastalıkları ve hemşirelik bakımı. Akdemir N, Birol L, editörler. İç Hastalıkları ve Hemşirelik Bakımı. Akademisyen Kitabevi A.Ş., s. 1151-1152.
  • Alankaya N. (2019). Guillain-Barré sendromu ve bakım yönetimi. Özer S, editör. Olgu Senaryolarıyla İç Hastalıkları Hemşireliği. İstanbul Medikal Sağlık ve Yayıncılık Hiz. Tic. Ltd. Şti., s. 395-400.
  • Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P ve ark. (2020). Guillain-Barré syndrome related to COVID-19 infection. Neurology(R) Neuroimmunology and Neuroinflammation, 7(4), 741.
  • Arnaud S, Budowski C, Ng Wing Tin S, Degos B. (2020). Post SARS-CoV-2 Guillain-Barré syndrome. Clinical Neurophysiology: Official Journal of The International Federationof Clinical Neurophysiology, 131(7), 1652–1654.
  • Askanase AD, Khalili L, Buyon JP. (2020). Thoughts on COVID-19 and autoimmune diseases. Lupus Science & Medicine, 7(1), e000396.
  • Atkinson SB, Carr RL, Maybee P, Haynes D. (2006). The challenges of managing and treating Guillain-Barré syndrome during the acute phase. Dimensions of Critical Care Nursing: DCCN, 25(6), 256–263.
  • Bernsen RA, De Jager AE, Van der Meché FG, Suurmeijer TP. (2006). The effects of Guillain-Barré syndrome on the close relatives of patients during the first year. Journal of The Neurological Sciences, 244(1-2), 69–75.
  • Burns TM. (2008). Guillain-Barré syndrome. Seminars in Neurology, 28(2), 152–167.
  • Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E. (2020). COVID-19 may induce guillain-barré syndrome. Revue Neurologique, 176(6), 516–518.
  • Dash S, Pai AR, Kamath U, Rao P. (2015). Pathophysiology and diagnosis of Guillain-Barré syndrome-challenges and needs. The International Journal of Neuroscience, 125(4), 235–240. Defabio AC, Scott TR, Stenberg RT, Simon EL. (2020). Guillain-Barré syndrome in a patient previously diagnosed with COVID-19. The American Journal of Emergency Medicine, S0735-6757(20)30669-0. Advance online publication.
  • Dimachkie MM, Barohn RJ. (2013). Guillain-Barré syndrome and variants. Neurologic Clinics, 31(2), 491–510.
  • Erşil S, Sivrikaya SK. (2016). Kronik hastalıklarda evde bakımda hasta güvenliği. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 3(3), 426-430.
  • Farmakidis C, Inan S, Milstein M, Herskovitz S. (2015). Headache and pain in Guillain-Barré syndrome. Current Pain and Headache Reports, 19(8), 40.
  • Gazioğlu S, Tomak T, Boz C. (2013). Guillain-Barré Sendromunda klinik özellikler ve prognoz. Journal of Neurological Sciences, 30(1), 124-134. Haldeman D, Zulkosky K. (2005). Treatment and nursing care for a patient with guillain-barré syndrome. Dimensions of Critical Care Nursing: DCCN, 24(6), 267–272.
  • Harms M. (2011). Inpatient management of guillain-barré syndrome. The Neurohospitalist, 1(2), 78–84.
  • Hughes RA, Cornblath DR. (2005a). Guillain-Barré syndrome. Lancet (London, England), 366(9497), 1653–1666.
  • Hughes RA, Wijdicks EF, Benson E, Cornblath DR, Hahn AF, Meythaler JM ve ark. (2005b). Supportive care for patients with guillain-barré syndrome. Archives of Neurology, 62(8), 1194–1198.
  • Hughes RA, Swan AV, Van Doorn PA. (2014). Intravenous immunoglobulin for Guillain-Barré syndrome. The Cochrane Database of Systematic Reviews, 2014(9): CD002063.
  • Jorge LL, De Brito AM, Marchi FH, Hara AC, Battistella LR, Riberto M. (2015). New rehabilitation models for neurologic inpatients in Brazil. Disability and Rehabilitation, 37(3), 268–273.
  • Kasar KS, Karadakovan A. (2017). Guillain-Barré sendromu ve bakım yönetimi. Türkiye Klinikleri Hemşirelik Bilimleri Dergisi, 9(1), 79-84.
  • Leonhard SE, Mandarakas MR, Gondim F, Bateman K, Ferreira M, Cornblath DR . (2019). Diagnosis and management of Guillain-Barré syndrome in ten steps. Nature Reviews. Neurology, 15(11), 671–683.
  • Li YC, Bai WZ, Hashikawa T. (2020). The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. Journal of Medical Virology, 92(6), 552–555.
  • Meena AK, Khadilkar SV, Murthy JM. (2011). Treatment guidelines for Guillain-Barré syndrome. Annals of Indian Academy of Neurology, 14(Suppl 1), 73–81.
  • Mollaoğlu M. (2017). Sinir sistemi hastalıkları ve hemşirelik yönetimi. Ovayolu N, Ovayolu Ö, editörler. Temel İç Hastalıkları Hemşireliği ve Farklı Boyutları İle Kronik Hastalıklar. Çukurova Nobel Tıp Kitabevi, s. 83-84.
  • Newswanger DL, Warren CR. (2004). Guillain-Barré syndrome. American Family Physician, 69(10), 2405–2410.
  • Peric S, Milosevic V, Berisavac I, Stojiljkovic O, Beslac-Bumbasirevic L, Marjanovic I ve ark. (2014). Clinical and epidemiological features of Guillain-Barré syndrome in the Western Balkans. Journal of The Peripheral Nervous System: JPNS, 19(4), 317–321.
  • Prada V, Massa F, Salerno A, Fregosi D, Beronio A, Serrati C et al. (2020). Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study. Neurological Sciences, 41(2), 321-327.
  • Rajagopalan S, Baghshomali S, Navarro JC, Kalanuria AA. (2018). Intensive care management of the neuromuscular patient. Textbook of Neuroanesthesia and Neurocritical Care: Volume II - Neurocritical Care, 63–96.
  • Ranjani P, Khanna M, Gupta A, Nagappa M, Taly AB, Haldar P. (2014). Prevalence of fatigue in Guillain-Barré syndrome in neurological rehabilitation setting. Annals of Indian Academy of Neurology, 17(3), 331–335.
  • Sedaghat Z, Karimi N. (2020). Guillain-Barré syndrome associated with COVID-19 infection: A case report. Journal of Clinical Neuroscience: Official Journal of The Neurosurgical Society of Australasia, 76, 233–235. Simatos Arsenault N, Vincent PO, Yu BH, Bastien R, Sweeney A. (2016). Influence of exercise on patients with Guillain-Barré Syndrome: A Systematic Review. Physiotherapy Canada. Physiotherapie Canada, 68(4), 367–376.
  • Sudulagunta SR, Sodalagunta MB, Sepehrar M, Khorram H, Bangalore Raja SK, Kothandapani S ve ark. (2015). Guillain-Barré syndrome: clinical profile and management. German Medical Science: GMS e-journal, 13, Doc16.
  • Sulton LL. (2001). A multidisciplinary care approach to Guillain-Barré syndrome. Dimensions of Critical Care Nursing: DCCN, 20(1), 16–22.
  • Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. (2014). Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews. Neurology, 10(8), 469–482.
  • Vucic S, Kiernan MC, Cornblath DR. (2009). Guillain-barré syndrome: an update. Journal of Clinical Neuroscience: Official Journal of The Neurosurgical Society of Australasia, 16(6), 733–741.
  • Walling AD, Dickson G. (2013). Guillain-Barré syndrome. American Family Physician, 87(3), 191–197.
  • Wilkinson JM, Barcus L. (2018). Nursing Diagnosis Handbook. Kapucu S, Akyar İ, Korkmaz F, çeviri editörleri. Hemşirelik Tanıları El Kitabı. Pelikan Kitabevi, s. 181;192
  • Yao S, Chen H, Zhang Q, Shi Z, Liu J, Lian Z ve ark. (2018). Pain during the acute phase of Guillain-Barré syndrome. Medicine, 97(34), e11595.
Toplam 37 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Hemşirelik
Bölüm Derleme
Yazarlar

Sibel Karaca Sivrikaya 0000-0001-5271-7757

İlknur Günay 0000-0002-9348-6200

Yayımlanma Tarihi 31 Aralık 2020
Gönderilme Tarihi 13 Temmuz 2020
Yayımlandığı Sayı Yıl 2020

Kaynak Göster

APA Karaca Sivrikaya, S., & Günay, İ. (2020). Nöromüsküler Bir Hastalık: Guillain Barré Sendromu ve Hemşirelik Bakımı. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi, 3(3), 338-346. https://doi.org/10.38108/ouhcd.768684